IN191482B - - Google Patents

Info

Publication number
IN191482B
IN191482B IN454DE1999A IN191482B IN 191482 B IN191482 B IN 191482B IN 454DE1999 A IN454DE1999 A IN 454DE1999A IN 191482 B IN191482 B IN 191482B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Gour Mukherji
Manoj Kumar
Himadrisen
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN454DE1999 priority Critical patent/IN191482B/en
Priority to AU62246/99A priority patent/AU6224699A/en
Priority to PCT/IB1999/001735 priority patent/WO2000056266A2/en
Priority to CNA998165883A priority patent/CN1615121A/zh
Priority to BR9917219-4A priority patent/BR9917219A/pt
Priority to EP99949283A priority patent/EP1235556A4/en
Priority to ZA200007724A priority patent/ZA200007724B/xx
Publication of IN191482B publication Critical patent/IN191482B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/501Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
IN454DE1999 1999-03-19 1999-03-19 IN191482B (pt)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IN454DE1999 IN191482B (pt) 1999-03-19 1999-03-19
AU62246/99A AU6224699A (en) 1999-03-19 1999-10-26 Taste masking coating compositions
PCT/IB1999/001735 WO2000056266A2 (en) 1999-03-19 1999-10-26 Taste masking coating compositions
CNA998165883A CN1615121A (zh) 1999-03-19 1999-10-26 掩盖味道的包衣组合物
BR9917219-4A BR9917219A (pt) 1999-03-19 1999-10-26 Composições de revestimento para mascaramento de sabor
EP99949283A EP1235556A4 (en) 1999-03-19 1999-10-26 COATINGS FOR TASTE MASKING
ZA200007724A ZA200007724B (en) 1999-03-19 2001-09-19 Taste masking coating compositions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN454DE1999 IN191482B (pt) 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
IN191482B true IN191482B (pt) 2003-12-06

Family

ID=11089863

Family Applications (1)

Application Number Title Priority Date Filing Date
IN454DE1999 IN191482B (pt) 1999-03-19 1999-03-19

Country Status (7)

Country Link
EP (1) EP1235556A4 (pt)
CN (1) CN1615121A (pt)
AU (1) AU6224699A (pt)
BR (1) BR9917219A (pt)
IN (1) IN191482B (pt)
WO (1) WO2000056266A2 (pt)
ZA (1) ZA200007724B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN191239B (pt) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
AU2002327418A1 (en) * 2001-08-01 2003-02-17 Bristol-Myers Squibb Company Taste masking composition
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
WO2003072089A1 (en) 2002-02-21 2003-09-04 Biovail Laboratories Inc. Controlled release dosage forms
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
US8889184B2 (en) * 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
US5843482A (en) * 1990-07-20 1998-12-01 Tillotts Pharma Ag Products and processes for the treatment of the alimentary canal
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
JP3839467B2 (ja) * 1992-06-04 2006-11-01 スミスクライン・ビーチャム・コーポレイション 味の良い医薬組成物
DE19709532A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen

Also Published As

Publication number Publication date
EP1235556A2 (en) 2002-09-04
WO2000056266A3 (en) 2002-07-04
EP1235556A4 (en) 2003-07-16
BR9917219A (pt) 2002-04-23
CN1615121A (zh) 2005-05-11
AU6224699A (en) 2000-10-09
ZA200007724B (en) 2002-06-12
WO2000056266A2 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
BE2015C018I2 (pt)
BE2014C017I2 (pt)
BE2013C051I2 (pt)
BE2013C020I2 (pt)
BE2013C015I2 (pt)
BE2013C001I2 (pt)
BE2012C036I2 (pt)
BE2011C004I2 (pt)
BE2010C011I2 (pt)
BE1025464I2 (pt)
JP2002524735A5 (pt)
BE2008C046I2 (pt)
JP2002513254A5 (pt)
JP2002507835A5 (pt)
BRPI0017527B8 (pt)
JP2001118250A5 (pt)
JP2002527967A5 (pt)
JP2002505453A5 (pt)
BE2008C047I2 (pt)
BRPI0001672A2 (pt)
JP2002516393A5 (pt)
JP2002531727A5 (pt)
JP2002524148A5 (pt)
JP2002528838A5 (pt)
JP2002523514A5 (pt)